|
1
|
Hypertension in pregnancy, . Report of the
American College of Obstetricians and Gynecologists' Task Force on
Hypertension in Pregnancy. Obstet Gynecol. 122:1122–1131.
2013.PubMed/NCBI
|
|
2
|
Shu W, Li H, Gong H, Zhang M, Niu X, Ma Y,
Zhang X, Cai W, Yang G, Wei M, et al: Evaluation of blood vessel
injury, oxidative stress and circulating inflammatory factors in an
L-NAME-induced preeclampsia-like rat model. Exp Ther Med.
16:585–594. 2018.PubMed/NCBI
|
|
3
|
Kemse NG, Kale AA and Joshi SR:
Supplementation of maternal omega-3 fatty acids to pregnancy
induced hypertension Wistar rats improves IL10 and VEGF levels.
Prostaglandins Leukot Essent Fatty Acids. 104:25–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuklina EV, Ayala C and Callaghan WM:
Hypertensive disorders and severe obstetric morbidity in the United
States. Obstet Gynecol. 113:1299–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lisonkova S and Joseph KS: Incidence of
preeclampsia: Risk factors and outcomes associated with
early-versus late-onset disease. Am J Obstet Gynecol.
209:544.e1–544 e12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hladunewich M, Karumanchi SA and Lafayette
R: Pathophysiology of the clinical manifestations of preeclampsia.
Clin J Am Soc Nephrol. 2:543–549. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roberts JM and Gammill HS: Preeclampsia:
Recent insights. Hypertension. 46:1243–1249. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Llurba E, Crispi F and Verlohren S: Update
on the pathophysiological implications and clinical role of
angiogenic factors in pregnancy. Fetal Diagn Ther. 37:81–92. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Verlohren S, Stepan H and Dechend R:
Angiogenic growth factors in the diagnosis and prediction of
pre-eclampsia. Clin Sci (Lond). 122:43–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maynard SE and Karumanchi SA: Angiogenic
factors and preeclampsia. Semin Nephrol. 31:33–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henao DE and Saleem MA: Proteinuria in
preeclampsia from a podocyte injury perspective. Curr Hypertens
Rep. 15:600–605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roberts JM and Escudero C: The placenta in
preeclampsia. Pregnancy Hypertens. 2:72–83. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen W, Xiang H, Chen R, Yang J, Yang X,
Zhou J, Liu H, Zhao S, Xiao J, Chen P, et al: S1PR2 antagonist
ameliorate high glucose-induced fission and dysfunction of
mitochondria in HRGECs via regulating ROCK1. BMC Nephrol.
20:1352019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng JC, Wang EY, Yi Y, Thakur A, Tsai SH
and Hoodless PA: S1P stimulates proliferation by upregulating CTGF
expression through S1PR2-Mediated YAP activation. Mol Cancer Res.
16:1543–1555. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sanchez T and Hla T: Structural and
functional characteristics of S1P receptors. J Cell Biochem.
92:913–922. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Tang H, Sysol JR, Moreno-Vinasco
L, Shioura KM, Chen T, Gorshkova I, Wang L, Huang LS, Usatyuk PV,
et al: The sphingosine kinase 1/sphingosine-1-phosphate pathway in
pulmonary arterial hypertension. Am J Respir Crit Care Med.
190:1032–1043. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ikeda H, Nagashima K, Yanase M, Tomiya T,
Arai M, Inoue Y, Tejima K, Nishikawa T, Watanabe N, Omata M and
Fujiwara K: Sphingosine 1-phosphate enhances portal pressure in
isolated perfused liver via S1P2 with Rho activation. Biochem
Biophys Res Commun. 320:754–759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schapiro SA and Everitt JI: Preparation of
animals for use in the laboratory: Issues and challenges for the
Institutional Animal Care and Use Committee (IACUC). ILAR J.
47:370–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
LaMarca BB, Bennett WA, Alexander BT,
Cockrell K and Granger JP: Hypertension produced by reductions in
uterine perfusion in the pregnant rat: Role of tumor necrosis
factor-alpha. Hypertension. 46:1022–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chawla S, Rahar B and Saxena S: S1P
prophylaxis mitigates acute hypobaric hypoxia-induced molecular,
biochemical, and metabolic disturbances: A preclinical report.
IUBMB Life. 68:365–375. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Westwood M, Al-Saghir K, Finn-Sell S, Tan
C, Cowley E, Berneau S, Adlam D and Johnstone ED: Vitamin D
attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of
extravillous trophoblast migration. Placenta. 60:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dobierzewska A, Palominos M, Sanchez M,
Dyhr M, Helgert K, Venegas-Araneda P, Tong S and Illanes SE:
Impairment of Angiogenic Sphingosine
Kinase-1/Sphingosine-1-Phosphate receptors pathway in preeclampsia.
PLoS One. 11:e01572212016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pavlov N, Frendo JL, Guibourdenche J,
Degrelle SA, Evain-Brion D and Badet J: Angiogenin expression
during early human placental development; association with blood
vessel formation. Biomed Res Int. 2014:7816322014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Santos TC, Oliveira MF, Papa PC, Dantzer V
and Miglino MA: VEGF system expression by immunohistochemistry and
real-time RT-PCR study on collared peccary placenta.
Theriogenology. 82:834–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Su Z, Li J, Wang Q, Meng G, Zhang Y,
Yang W, Zhang J and Gao P: Role of RNA-binding protein 5 in the
diagnosis and chemotherapeutic response of lung cancer. Oncol Lett.
17:2013–2019. 2019.PubMed/NCBI
|
|
27
|
Adu-Bonsaffoh K, Antwi DA, Gyan B and Obed
SA: Endothelial dysfunction in the pathogenesis of pre-eclampsia in
Ghanaian women. BMC Physiol. 17:52017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luttun A and Carmeliet P: Soluble VEGF
receptor Flt1: The elusive preeclampsia factor discovered? J Clin
Invest. 111:600–602. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Motta-Mejia C, Kandzija N, Zhang W, Mhlomi
V, Cerdeira AS, Burdujan A, Tannetta D, Dragovic R, Sargent IL,
Redman CW, et al: Placental vesicles carry active endothelial
nitric oxide synthase and their activity is reduced in
preeclampsia. Hypertension. 70:372–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amaral LM, Pinheiro LC, Guimaraes DA,
Palei AC, Sertório JT, Portella RL and Tanus-Santos JE:
Antihypertensive effects of inducible nitric oxide synthase
inhibition in experimental pre-eclampsia. J Cell Mol Med.
17:1300–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramos JGL, Sass N and Costa SHM:
Preeclampsia. Rev Bras Ginecol Obstet. 39:496–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Terlecky SR, Terlecky LJ and Giordano CR:
Peroxisomes, oxidative stress, and inflammation. World J Biol Chem.
3:93–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roy S, Dhobale M, Dangat K, Mehendale S,
Lalwani S and Joshi S: Differential oxidative stress levels in
mothers with preeclampsia delivering male and female babies. J
Matern Fetal Neonatal Med. 28:1973–1980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raio L, Bersinger NA, Malek A, Schneider
H, Messerli FH, Hürter H, Rimoldi SF and Baumann MU: Ultra-high
sensitive C-reactive protein during normal pregnancy and in
preeclampsia: A pilot study. J Hypertens. 37:1012–1017. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Black KD and Horowitz JA: Inflammatory
markers and preeclampsia: A systematic review. Nurs Res.
67:242–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
